Evolent Health, Inc. - Laporan Laba Rugi (TTM)

Evolent Health, Inc.
US ˙ NYSE ˙ US30050B1017

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Evolent Health, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 915 925 918 923 906 908 990 1,088 1,218 1,352 1,483 1,632 1,790 1,964 2,176 2,354 2,464 2,555 2,399 2,196
Change (%) 1.09 -0.67 0.52 -1.85 0.20 9.03 9.89 11.96 11.01 9.66 10.06 9.71 9.70 10.79 8.18 4.69 3.67 -6.11 -8.46
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 704 697 679 687 668 658 719 797 901 1,035 1,126 1,228 1,348 1,503 1,728 1,917 2,071 2,187 2,033 1,837
Change (%) -1.10 -2.55 1.14 -2.71 -1.55 9.41 10.78 12.98 14.98 8.76 9.08 9.77 11.50 14.97 10.90 8.04 5.62 -7.06 -9.66
% of Revenue 77.01 75.34 73.90 74.36 73.71 72.42 72.68 73.27 73.94 76.58 75.96 75.28 75.32 76.55 79.44 81.43 84.04 85.62 84.75 83.64
Gross Operating Profit 210 228 240 237 238 250 270 291 317 317 356 403 442 460 447 437 393 367 366 359
Change (%) 8.46 5.10 -1.25 0.65 5.11 8.02 7.50 9.16 -0.26 12.60 13.17 9.53 4.20 -2.85 -2.31 -10.01 -6.59 -0.45 -1.77
% of Revenue 22.99 24.66 26.10 25.64 26.29 27.58 27.32 26.73 26.06 23.42 24.04 24.72 24.68 23.45 20.56 18.57 15.96 14.38 15.25 16.36
SG&A 196 198 197 199 199 208 215 229 243 269 263 298 327 306 298 275 248 247 255 261
Change (%) 0.90 -0.28 0.57 0.14 4.48 3.48 6.35 6.49 10.59 -2.19 13.34 9.53 -6.32 -2.82 -7.77 -9.58 -0.62 3.22 2.68
% of Revenue 21.46 21.42 21.50 21.51 21.95 22.88 21.72 21.02 19.99 19.92 17.76 18.29 18.26 15.60 13.68 11.66 10.07 9.65 10.61 11.90
R&D
Change (%)
% of Revenue
OpEx 963 955 936 944 926 925 994 1,086 1,207 1,372 1,471 1,625 1,789 1,933 2,150 2,313 2,438 2,552 2,401 2,204
Change (%) -0.75 -2.00 0.87 -1.91 -0.12 7.46 9.19 11.11 13.71 7.22 10.50 10.07 8.06 11.21 7.58 5.41 4.70 -5.95 -8.18
% of Revenue 105.26 103.33 101.94 102.30 102.24 101.92 100.45 99.82 99.06 101.47 99.21 99.60 99.92 98.43 98.80 98.25 98.93 99.91 100.07 100.38
Operating Income -48 -31 -18 -21 -20 -17 -4 2 11 -20 12 7 1 31 26 41 26 2 -2 -8
Change (%) -35.91 -42.15 19.15 -4.36 -14.28 -74.30 -144.07 479.21 -274.05 -159.12 -44.17 -79.12 2,146.79 -15.22 57.58 -35.81 -91.16 -176.77 366.16
% of Revenue -5.26 -3.33 -1.94 -2.30 -2.24 -1.92 -0.45 0.18 0.94 -1.47 0.79 0.40 0.08 1.57 1.20 1.75 1.07 0.09 -0.07 -0.38
Interest Expense -24 -28 -28 -28 -27 -25 -21 -17 -16 -16 -26 -39 -48 -54 -47 -39 -30 -25 -29 -35
Change (%) 19.47 0.20 -0.06 -3.70 -6.92 -16.11 -19.34 -9.38 -0.12 68.42 46.94 25.59 12.00 -12.73 -17.89 -22.15 -18.25 17.75 19.26
% of Revenue -2.59 -3.06 -3.09 -3.07 -3.01 -2.80 -2.15 -1.58 -1.28 -1.15 -1.77 -2.36 -2.70 -2.76 -2.17 -1.65 -1.23 -0.97 -1.21 -1.58
Net Income -518 -334 -265 -71 -47 -38 -33 -29 -13 -19 -34 -64 -91 -113 -110 -74 -72 -62 -109 -130
Change (%) -35.44 -20.63 -73.28 -34.29 -19.27 -11.85 -13.63 -52.97 42.36 76.35 87.98 43.20 24.25 -2.39 -32.55 -2.94 -14.69 76.82 19.73
% of Revenue -56.60 -36.15 -28.88 -7.68 -5.14 -4.14 -3.35 -2.63 -1.11 -1.42 -2.28 -3.89 -5.08 -5.76 -5.07 -3.16 -2.93 -2.41 -4.54 -5.94

Source: Capital IQ

Other Listings
DE:9EH € 8.15
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista